Butyrylcholinesterase K variants increase the risk of coronary artery disease in the population of western Iran

References

• Garcia M. J., McNamara P. M., Gordon T., Kannel W. B. Morbidity and mortality in diabetics in the Framingham population. Sixteen year follow‐up study. Diabetes 1974; 23: 105–11
   PubMed Web of Science ®Google Scholar
• Haffner S. M., Lehto S., Ronnemaa T., Pyorala K., Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in non‐diabetic subjects with and without prior myocardial infarction. N Engl J Med 1998; 339: 229–34
   PubMed Web of Science ®Google Scholar
• Schmitz F., Mevissen V., Krantz C., Kimmel M., Erdmann J., Hoffmann R., et al. Robust association of the APOE _4 allele with premature myocardial infarction especially in patients without hypercholesterolaemia: the Aachen study. Eur J Clin Invest 2007; 37: 106
   Google Scholar
• Jaikaran E. T. A. S., Clark A. Islet amyloid and Type 2 diabetes: from molecular misfolding to islet pathophysiology. Biochim Biophys Acta 2001; 1537: 179–203
   PubMed Web of Science ®Google Scholar
• Haberbosch W., Gardemann A. Gelatinase B C(−1562)T polymorphism in relation to ischaemic heart disease. Scand J Clin Lab Invest 2005; 65: 513–22
   PubMed Web of Science ®Google Scholar
• Pildal J., Lajer M., Hansen S. K., et al. Studies of variability in the islet amyloid polypeptide gene in relation to Type 2 diabetes. Diabet Med 2003; 20: 491–4
   Google Scholar
• Primo‐Parmo S. L., Bartels C. F., Wiersema B., van der Spek A. F. L., Innis J. W., La Du B. N. Characterization of 12 silent alleles of the human butyrylcholinesterase (BCHE) gene. Am J Hum Genet 1996; 58: 52–64
   Google Scholar
• Bartels C. F., Jensen F. S., Lockridge O., et al. DNA mutation associated with the human butyrylcholinesterase K variant and its linkage the atypical variant mutation and other polymorphic sites. Am J Hum Genet 1992; 50: 1086–103
   PubMed Web of Science ®Google Scholar
• Yen T., Nightingale B. N., Burns J. C., Sullivan D. R., Stewart P. M. Butyrylcholinesterase (BCHE) genotyping for post‐succinylcholine apnea in an Australian population. Clin Chem 2003; 49: 1297–308
   PubMed Web of Science ®Google Scholar
• Souza R. L., Mikami L. R., Maegawa R. O., Chautard‐Freire‐Maia E. A. Four new mutations in the BCHE gene of human butyrylcholinesterase in a Brazilian blood donor sample. Mol Genet Metab 2005; 84: 349–53
   PubMed Web of Science ®Google Scholar
• Pepys M. B., Hawkins P. N., Booth D. R., et al. Human lysozyme gene mutations cause hereditary systemic amyloidosis. Nature 1993; 362: 553–7
   PubMed Web of Science ®Google Scholar
• Hashim Y., Shepherd D., Wiltshire S., Holman R. R., Levy J. C., Clark A., et al. Butyrylcholinesterase K variant on chromosome 3 q is associated with Type II diabetes in white Caucasian subjects. Diabetologia 2001; 44: 2227–30
   PubMed Web of Science ®Google Scholar
• Lepienski L. M., Souza R. L., Chautard‐Freire‐Maia E. A., Alcantara V. M., Rea R. R. Variant K of butyrylcholinesterase and risk of early‐onset type 1 diabetes mellitus in Euro‐Brazilians. Diabetes Obes Metab 2006; 8: 709–11
   Google Scholar
• Johansen A., Nielsen E. M., Andersen G., Hamid Y. H., Jensen D. P., Glumer C., et al. Large‐scale studies of the functional K variant of the butyrylcholinesterase gene in relation to Type 2 diabetes and insulin secretion. Diabetologia 2004; 47: 1437–41
   PubMed Web of Science ®Google Scholar
• Nassar B. A., Rockwood K., Kirkland S. A., Ransom T. P., Darvesh S., Macpherson K., et al. Improved prediction of early‐onset coronary artery disease using APOE epsilon4, BChE‐K, PPARgamma2 Pro12 and ENOS T‐786C in a polygenic model. Clin Biochem Clin Iochem 2006; 39: 109–14
   PubMedGoogle Scholar
• Nassar B. A., Darvesh S., Bevin L. D., Rockwood K., Kirkland S. A., O'Neill B. J., et al. Relation between butyrylcholinesterase K variant, paraoxonase 1 (PON1) Q and R and apolipoprotein E epsilon 4 genes in early‐onset coronary artery disease. Clin Biochem 2002; 35: 205–9
   Google Scholar
• Raygani A. V., Zahrai M., Solt Anzadeh A., Doosti M., Javadi E., Pourmotabbed T. Analysis of association between butyrylcholinesterase K variant and apolipoprotein E genotypes in Alzheimer's disease. Neurosci Lett 2004; 371: 142–6
   PubMed Web of Science ®Google Scholar
• Judkins M. P. Selective coronary arteriography. I. A percutaneous transfemoral technique. Radiology 1967; 89: 815–24
   PubMed Web of Science ®Google Scholar
• WHO Study Group Report of a WHO consultation. Part 1: Diagnosis and classification of diabetes mellitus. World Health Organization, Geneva 1999
   Google Scholar
• Johan S. W. M., Weitzner G., Rozen R. A rapid procedure for extracting genomic DNA from leukocytes. Nucleic Acids Res 1991; 19: 408
   Google Scholar
• Jenese F. S., Nielsen L. R., Schwartz M. Detection of the plasma cholinesterase K variant by PCR using amplification‐created restriction site. Hum Heard 1996; 46: 26–31
   Web of Science ®Google Scholar
• Arnaud J., Brun R., Liobera R., Constans J. Serum cholinesterase polymorphism in France: an epidemiological survey of the deficient alleles detected by an automated micro‐method. Ann Hum Biol 1991; 18: 1–8
   PubMed Web of Science ®Google Scholar
• Garry P. J. A manual and automated procedure for measuring serum cholinesterase activity and identifying enzyme variants. Differentiation by means of Tris and phosphate buffers. Clin Chem 1971; 16: 183–91
   Google Scholar
• Boutin D., Brodeur J. An automated method for simultaneous determination of serum pseudocholinesterase activity, dibucaine number and fluoride number. Clin Biochem 1990; 23: 423–31
   PubMed Web of Science ®Google Scholar
• Vaisi‐Raygani A., Rahimi Z., Kharazi H., Tavilani H., Aminian M., Poumotabbed T., et al. Determination of butyrylcholinesterase (BChE) phenotypes to predict the risk of prolonged apnea in persons receiving succinylcholine in the healthy population of western Iran. Clin Biochem 2007; 40: 629–33
   PubMed Web of Science ®Google Scholar
• Alcantara V. M., Chautard‐Freire‐Maia E. A., Scartezini M., Cerci M. S., Braun‐Prado K., Picheth G. Butyrylcholinesterase activity and risk factors for coronary artery disease. Scand J Clin Lab Invest 2002; 62: 399–404
   PubMed Web of Science ®Google Scholar
• Rustemeijer R., Schouten J. A., Voerman H. J., Beyenen A. C., Donker A. J. M., Heine R. J. Is pseudocholinesterase activity related to markers of triacylglycerol synthesis in Type II diabetes mellitus?. Clin Sci 2001; 101: 29–35
   Google Scholar
• Humphries S. E., Ridker P. M., Talmud P. J. Genetic testing for cardiovascular disease susceptibility: a useful clinical management tool or possible misinformation. Arterioscler Thromb Vasc Biol 2004; 24: 628–36
   PubMedGoogle Scholar
• Gandelman G., Bodenheimer M. M. Screening coronary arteriography in the primary prevention of coronary artery disease. Heart Dis 2003; 5: 335–44
   PubMedGoogle Scholar
• Yamada Y., Izawa H., Ichihara S., et al. Prediction of the risk of myocardial infarction from polymorphism in candidate genes. N Engl J Med 2002; 347: 1916–23
   PubMed Web of Science ®Google Scholar
• Lehmann D. J., Johnston C., Smith A. D. Synergy between the genes for butyrylcholinesterase K variant and apolipoprotein E4 in late‐onset confirmed Alzheimer's disease. Hum Mol Genet 1997; 6: 1933–6
   PubMed Web of Science ®Google Scholar
• Thomas T., Thomas G., McLendon C., Sutton T., Mullan M. β‐amyloid mediated vasoactivity, and vascular endothelial damage. Nature 1996; 380: 168–71
   PubMed Web of Science ®Google Scholar
• Altamirano C. V., Bartels C. F., Lockridge O. The butyrylcholinesterase K‐variant shows cellular protein turnover and quaternary interaction to the wild‐type enzyme. J Neurochem 2000; 74: 869–77
   Google Scholar
• Lehmann D. J., Nagy Z., Litchfield S., Cortina Borja M., Smith D. A. Association of butyrylcholinesterase K variant with cholinesterase‐positive neuritic plaques in the temporal cortex in late‐onset Alzheimer's disease. Hum Genet 2000; 106: 447–52
   PubMed Web of Science ®Google Scholar
• Kutty K. M., Rowden G., Cox A. R. Interrelationship between serum β‐lipoprotein and cholinesterase. Can J Biochem 1973; 51: 883–7
   Google Scholar
• Randell E. W., Mathews M. S., Zhang H., Seraj J. S., Sun G. Relationship between serum butyrylcholinesterase and the metabolic syndrome. Clin Biochem 2005; 38: 799–805
   PubMed Web of Science ®Google Scholar
• Abbott C. A., Mackness M. I., Kumar S., Olukoga A. O., Gordon C., Arrol S., et al. Relationship between butyrylcholinesterase activity, hypertriglyceridemia and insulin sensitivity in diabetes mellitus. Clin Sci 1993; 85: 77–81
   PubMed Web of Science ®Google Scholar
• Sridhar G. R., Nirmala G., Apparao A., Madhavi A. S., Sreelatha S., Rani S., et al. Serum butyrylcholinesterase in type 2 diabetes mellitus: a biochemical and bioinformatics approach. Lipids Health Dis 2005; 4: 1–5
   Google Scholar
• Rao A. A., Sridhar G. R., Das U. N. Elevated butyrylcholinesterase and acetylcholinesterase may predict the development of type 2 diabetes mellitus and Alzheimer's disease. Med Hypotheses 2007, In press
   Google Scholar